# Venus-Vitae Pivotal Study Smart-Align Study

Study · id `cardio:ct-nct05991271` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05991271](<https://clinicaltrials.gov/study/NCT05991271>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05991271

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05991271. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-31 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05991271, source copy `cardio:ctgov-nct05991271-2023-08-18`, retrieved 2026-10-26)
- Planned start: 2023-10-31 (anticipated) (ClinicalTrials.gov record NCT05991271, source copy `cardio:ctgov-nct05991271-2023-08-18`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT05991271, source copy `cardio:ctgov-nct05991271-2023-08-18`, retrieved 2026-10-26)
- Completion: 2029-06-30 (anticipated) (ClinicalTrials.gov record NCT05991271, source copy `cardio:ctgov-nct05991271-2023-08-18`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05991271-2023-08-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Venus-Vitae Pivotal Study Smart-Align Study
- Condition: Aortic Valve Stenosis
- Intervention (Device): Venus-Vitae Transcatheter Heart Valve System
- Lead sponsor: Venus MedTech (HangZhou) Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 67d9e02d66cdb39c35e8bf4205f7fc04c27baadea5c2900f310ee1e141830e1f
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
